Cargando…
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
INTRODUCTION: The first generation ligands for prostate-specific membrane antigen (PSMA)–targeted radio- and fluorescence-guided surgery followed by adjuvant photodynamic therapy (PDT) have already shown the potential of this approach. Here, we developed three new photosensitizer-based dual-labeled...
Autores principales: | Derks, Yvonne H. W., van Lith, Sanne A. M., Amatdjais-Groenen, Helene I. V., Wouters, Lieke W. M., Kip, Annemarie, Franssen, Gerben M., Laverman, Peter, Löwik, Dennis W. P. M., Heskamp, Sandra, Rijpkema, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165289/ https://www.ncbi.nlm.nih.gov/pubmed/35029739 http://dx.doi.org/10.1007/s00259-022-05685-0 |
Ejemplares similares
-
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
por: Derks, Yvonne H. W., et al.
Publicado: (2023) -
Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer
por: Derks, Yvonne H.W., et al.
Publicado: (2021) -
Strain-Promoted Azide–Alkyne Cycloaddition-Based
PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection
of Prostate Cancer
por: Derks, Yvonne H. W., et al.
Publicado: (2021) -
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
por: Lütje, Susanne, et al.
Publicado: (2019) -
PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery
por: Derks, Yvonne H.W., et al.
Publicado: (2019)